1058 related articles for article (PubMed ID: 17117391)
21. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
[TBL] [Abstract][Full Text] [Related]
22. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
Jarboe EA; Miron A; Carlson JW; Hirsch MS; Kindelberger D; Mutter GL; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):308-15. PubMed ID: 19483636
[TBL] [Abstract][Full Text] [Related]
23. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
Folkins AK; Jarboe EA; Saleemuddin A; Lee Y; Callahan MJ; Drapkin R; Garber JE; Muto MG; Tworoger S; Crum CP
Gynecol Oncol; 2008 May; 109(2):168-73. PubMed ID: 18342932
[TBL] [Abstract][Full Text] [Related]
24. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
[TBL] [Abstract][Full Text] [Related]
25. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?
Roh MH; Kindelberger D; Crum CP
Am J Surg Pathol; 2009 Mar; 33(3):376-83. PubMed ID: 19011565
[TBL] [Abstract][Full Text] [Related]
26. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
[TBL] [Abstract][Full Text] [Related]
27. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.
Xian W; Miron A; Roh M; Semmel DR; Yassin Y; Garber J; Oliva E; Goodman A; Mehra K; Berkowitz RS; Crum CP; Quade BJ
J Pathol; 2010 Jan; 220(1):17-23. PubMed ID: 19834951
[TBL] [Abstract][Full Text] [Related]
28. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
29. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
Shaw PA; Rouzbahman M; Pizer ES; Pintilie M; Begley H
Mod Pathol; 2009 Sep; 22(9):1133-8. PubMed ID: 19543244
[TBL] [Abstract][Full Text] [Related]
30. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
31. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
[TBL] [Abstract][Full Text] [Related]
32. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.
Chen EY; Mehra K; Mehrad M; Ning G; Miron A; Mutter GL; Monte N; Quade BJ; McKeon FD; Yassin Y; Xian W; Crum CP
J Pathol; 2010 Sep; 222(1):110-6. PubMed ID: 20597068
[TBL] [Abstract][Full Text] [Related]
33. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
34. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
35. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
36. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.
Mehrad M; Ning G; Chen EY; Mehra KK; Crum CP
Adv Anat Pathol; 2010 Sep; 17(5):293-302. PubMed ID: 20733351
[TBL] [Abstract][Full Text] [Related]
37. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.
Bijron JG; van der Groep P; van Dorst EB; Seeber LM; Sie-Go DM; Verheijen RH; van Diest PJ
Endocr Relat Cancer; 2012 Feb; 19(1):69-81. PubMed ID: 22143498
[TBL] [Abstract][Full Text] [Related]
39. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
[TBL] [Abstract][Full Text] [Related]
40. Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers.
George SH; Greenaway J; Milea A; Clary V; Shaw S; Sharma M; Virtanen C; Shaw PA
J Pathol; 2011 Sep; 225(1):106-17. PubMed ID: 21744340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
